Log in to save to my catalogue

Large Granular Lymphocytic Leukemia: From Immunopathogenesis to Treatment of Refractory Disease

Large Granular Lymphocytic Leukemia: From Immunopathogenesis to Treatment of Refractory Disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8430581

Large Granular Lymphocytic Leukemia: From Immunopathogenesis to Treatment of Refractory Disease

About this item

Full title

Large Granular Lymphocytic Leukemia: From Immunopathogenesis to Treatment of Refractory Disease

Publisher

Switzerland: MDPI AG

Journal title

Cancers, 2021-09, Vol.13 (17), p.4418

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Large Granular Lymphocyte Leukemia (LGLL) is a rare, chronic lymphoproliferative disorder of effector cytotoxic T-cells, and less frequently, natural killer (NK) cells. The disease is characterized by an indolent and often asymptomatic course. However, in roughly 50% of cases, treatment is required due to severe transfusion-dependent anemia, severe...

Alternative Titles

Full title

Large Granular Lymphocytic Leukemia: From Immunopathogenesis to Treatment of Refractory Disease

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8430581

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8430581

Other Identifiers

ISSN

2072-6694

E-ISSN

2072-6694

DOI

10.3390/cancers13174418

How to access this item